AXA Hong Kong, CUHK, Oxford VR launch VR therapy solution
China | News | 0 Comment | 18 Jun, 2019
AXA Hong Kong, The Chinese University of Hong Kong (CUHK) and Oxford VR (OVR) have jointly launched a first-of...Read more
Terns Pharmaceuticals initiates Ph1 clinical trial of TERN 101
China | News | 0 Comment | 17 Jun, 2019
Terns Pharmaceuticals has announced the initiation of Phase 1 clinical trial of TERN-101, a farnesoid X receptor (F...Read more
China Focus@BIO Conference held in conjunction with 2019 BIO International Convention
China | News | 0 Comment | 17 Jun, 2019
Ms Kimberly Nearing, Head of Life Sciences at Cedrus Investments (Cedrus), was invited to moderate the fi...Read more
Reistone Announces First Patient Dosed in Two Phase II Global Studies of SHR0302
China | News | 0 Comment | 17 Jun, 2019
Reistone Biopharma Company Limited (Reistone), on 14 June 2019, announced dosing of the first patient in their Phase II ...Read more
111 to advance Internet and Healthcare
China | News | 0 Comment | 17 Jun, 2019
111, Inc., a leading integrated online and offline healthcare platform, on 13 June 2019, announced that it has signed a ...Read more
First Uzbekistani Company in Hong Kong to bring Chinese Medicine Business along "The Belt and Road"
China | News | 0 Comment | 14 Jun, 2019
"The Belt and Road" International Cocktail Reception of Chinese Medicine Innovation and Cooperation was held in Hon...Read more
China NMPA Approves Sinovant's Clinical Trial Application for Lefamulin
China | News | 0 Comment | 14 Jun, 2019
Sinovant Sciences announced on 13 June 2019, that its Clinical Trial Application (CTA) for lefamulin has been accepted b...Read more
Terns Pharmaceuticals and Shanghai Tuosheng Biotechnology initiate TERN-101 first phase trial
China | News | 0 Comment | 14 Jun, 2019
Terns Pharmaceuticals, Inc. and Shanghai Tuo Zhen Biological Technology Co., Ltd., on 13 June 2019, announced the launch...Read more
Inaugural Global Health Forum of Boao Forum for Asia held in China
China | News | 0 Comment | 14 Jun, 2019
The inaugural Global Health Forum (GHF) of Boao Forum for Asia (BFA) was held in Qingdao, China, from&nbs...Read more
Parexel teams up with CLARINESS for enhanced patient engagement in China
China | News | 0 Comment | 13 Jun, 2019
Parexel, a leader in the development of innovative new therapies to improve the world’s health has announced a str...Read more
China Aged Care Market focuses on Medical-Nursing Combined Care
China | News | 0 Comment | 12 Jun, 2019
The "China Aged Care Industry Report, 2019-2025" report has been added to ResearchAndMarkets.com's o...Read more
GT Healthcare Capital Partners launches AI-driven drug development company
China | News | 0 Comment | 14 Jun, 2019
GT Healthcare Capital Partners, a life science-focused private equity partnership which specializes in capital investmen...Read more
Deciphera Pharma, Zai Lab to bring anti-cancer drug in Greater China
China | News | 0 Comment | 13 Jun, 2019
Deciphera Pharmaceuticals, a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug...Read more
Calliditas Therapeutics to commercialize autoimmune drug in China, Singapore
China | News | 0 Comment | 11 Jun, 2019
Sweden based Calliditas Therapeutics AB (“Calliditas”) and US based Everest Medicines II Limited (“Eve...Read more
Ping An Good Doctor launches groundbreaking service
China | News | 0 Comment | 10 Jun, 2019
China based Ping An Healthcare and Technology Company Limited, the world's leading one-stop healthcare ecosystem platfor...Read more
CStone and Bayer to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib
China | News | 0 Comment | 10 Jun, 2019
CStone Pharmaceuticals, on 9 June 2019, announced its global clinical collaboration with China focus with Baye...Read more
Ascentage Pharma presents new clinical data of apoptosis targeted drug candidates
China | News | 0 Comment | 07 Jun, 2019
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for can...Read more
BioMarin receives approval for rare syndrome treatment in China
China | News | 0 Comment | 07 Jun, 2019
US based BioMarin Pharmaceutical Inc. has announced that Vimizim® (elosulfase alfa) has been approved by the Nationa...Read more